Page last updated: 2024-08-21

selenomethionine and Intraepithelial Prostatic Neoplasia

selenomethionine has been researched along with Intraepithelial Prostatic Neoplasia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
El-Bayoumy, K; Facompre, ND; Pinto, JT; Sinha, R; Sun, YW	1
Clark, LC; Marshall, JR	1

Trials

1 trial(s) available for selenomethionine and Intraepithelial Prostatic Neoplasia

Article	Year
Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia. Urology, 2001, Volume: 57, Issue:4 Suppl 1 Topics: Anticarcinogenic Agents; Arizona; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dietary Supplements; Double-Blind Method; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatectomy; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenomethionine; Skin Neoplasms	2001

Article

Year

Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia.

Urology, 2001, Volume: 57, Issue:4 Suppl 1

Topics: Anticarcinogenic Agents; Arizona; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dietary Supplements; Double-Blind Method; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatectomy; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenomethionine; Skin Neoplasms

2001

Other Studies

1 other study(ies) available for selenomethionine and Intraepithelial Prostatic Neoplasia

Article	Year
1,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells. Cancer prevention research (Philadelphia, Pa.), 2010, Volume: 3, Issue:8 Topics: Androgen Antagonists; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Evaluation, Preclinical; Humans; Male; Models, Biological; Oncogene Protein v-akt; Organoselenium Compounds; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Receptors, Androgen; Selenomethionine; Signal Transduction; Tumor Cells, Cultured	2010

Article

Year

1,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells.

Cancer prevention research (Philadelphia, Pa.), 2010, Volume: 3, Issue:8

Topics: Androgen Antagonists; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Evaluation, Preclinical; Humans; Male; Models, Biological; Oncogene Protein v-akt; Organoselenium Compounds; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Receptors, Androgen; Selenomethionine; Signal Transduction; Tumor Cells, Cultured

2010